Pulmonary Medicine News

 
  • Alert FDA Approves Trelegy Ellipta for COPD The FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with COPD.
  • Alert EMA Panel Backs Two New Inhalers for COPD Elebrato Ellipta and Trelegy Ellipta contain the triple combination of fluticasone furoate, umeclidinium, and vilanterol and are for inadequately controlled moderate to severe COPD in adults.

 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • 'MAP' Program Improves Hypertension ControlThe MAP program focuses on an accurate BP, intensifying treatment when an elevated BP is confirmed, and partnering with the patient to select and carry out the treatment plan.
  • FDA Approves Trelegy Ellipta for COPDThe FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with COPD.
  • AAP Offers First Guidance on Tattoos, PiercingsThe report from the American Academy of Pediatrics (AAP) is designed to facilitate conversations between providers, parents, and patients about the increasingly common desire for body modifications.
  • Standards for Upper GI Endoscopy ReleasedThe BSG and AUGIS jointly released recommendations to improve the quality of upper gastrointestinal endoscopy and reduce the risk for missed early cancerous lesions.

Perspective

Business of Medicine

Columnists

Advisory Board

 

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
potenzmittel kamagra

comprare viagra on-line senza ricetta

посмотреть

источник